The largest database of trusted experimental protocols

Hla b8 pe

Manufactured by Miltenyi Biotec

The HLA-B8-PE is a fluorochrome-conjugated monoclonal antibody that binds to the human leukocyte antigen (HLA) class I molecule HLA-B8. It is used for the identification and enumeration of HLA-B8-positive cells in flow cytometry applications.

Automatically generated - may contain errors

2 protocols using hla b8 pe

1

Quantifying HLA Expression in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA-ABC and HLA-B8 expression levels in cell lines were analyzed by staining with HLA-ABC-FITC (BD) and HLA-B8-PE (Miltenyi Biotec) antibodies, respectively. The HLA-negative cell line K562 was used to set the gates for HLA-ABC+ and HLA-B8+ cells. Data were acquired using a BD Canto II flow cytometer and analyzed using FlowJo. The antibodies used in this study are listed in online supplemental table S2.
+ Open protocol
+ Expand
2

Single-cell Flow Cytometry of Intestinal Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions from lamina propria were analyzed by flow cytometry according to standard procedure using fluorochrome-conjugated antibodies targeting HLA-A2–PE (Abcam); CD20-FITC, CD45-APC-H7, and Ki67-FITC (BD); Bcl2–Alexa Fluor 488, BCMA-PE, CD3-APC, CD14-APC, CD19–Alexa Flour 488/PE-Cy7, CD20-PE, CD27-BV421/Pacific blue/APC-Cy7/PE-Cy7, CD28–Alexa Fluor 488, CD38-PE/APC-Cy7, CD45-BV510/APC-Cy7, CD56–Alexa Flour 488, CD95-PE, and HLA-DR–BV605/PerCP (BioLegend); CD138-FITC/PE-Cy7 and HLA-A3–FITC/APC (eBioscience); HLA-B7–PE (EMD Millipore); HLA-B8–PE (Miltenyi Biotec); IgA-FITC/PE, IgM-FITC/PE, and IgD-FITC/PE (SouthernBiotech); and Blimp-1–DyLight 488 (Thermo Fisher Scientific). For detection of intracellular antigens, cells were fixed in formaldehyde and permeabilized using a Foxp3 staining buffer set (eBioscience). Detection of rotavirus-specific PCs was performed using eGFP-tagged virus-like particle 2 (VLP2)–eGFP/VLP6 (provided by D. Poncet and A. Charpilienne, Institut de Biologie Integrative de la Cellule, Paris, France; Charpilienne et al., 2001 (link)) at a final concentration of 1 µg/ml. eGFP (Promega) was used as a negative control. All flow cytometry was performed on an LSRFortessa, and FACS was performed on a FACSAriaII flow cytometer (both from BD). Data were analyzed using FlowJo 10 (Tree Star), and figures were assembled in Illustrator CS4 (Adobe).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!